recombin
viruslik
particl
vlp
shown
induc
protect
immun
despit
potenti
signific
promis
vaccin
candid
protein
composit
vlp
produc
insect
cell
well
character
report
proteom
analysi
influenza
vlp
contain
hemagglutinin
ha
matrix
protein
human
isol
avian
influenza
viru
vlp
produc
insect
cell
use
recombin
baculoviru
express
system
comprehens
proteom
analysi
purifi
vlp
identifi
viral
protein
addit
hostderiv
protein
mani
known
present
envelop
virus
protein
involv
differ
cellular
structur
function
found
present
vlp
includ
cytoskeleton
translat
chaperon
metabol
immun
purifi
vlp
induc
protect
immun
compar
inactiv
whole
viru
contain
viral
compon
unpurifi
vlp
contain
excess
amount
noninfluenza
solubl
protein
also
confer
protect
lethal
challeng
although
lower
immun
respons
induc
result
provid
import
implic
consist
idea
vlp
product
insect
cell
may
involv
similar
cellular
machineri
rna
envelop
virus
synthesi
assembl
traffick
bud
process
influenza
major
infecti
diseas
human
anim
caus
signific
morbid
mortal
worldwid
base
world
health
organ
report
http
estim
season
influenza
epidem
affect
global
popul
annual
respons
million
hospit
death
per
year
influenza
viru
circul
variou
reservoir
includ
human
bird
pig
show
continu
mutat
provid
sourc
emerg
novel
strain
exampl
novel
swineorigin
influenza
viru
declar
first
pandem
st
centuri
sinc
emerg
highli
pathogen
influenza
viru
hong
kong
recurr
outbreak
avian
influenza
virus
pose
greater
threat
human
case
shown
high
mortal
fold
higher
compar
season
influenza
virus
http
wwwwhointcsrdiseaseavianinfluenza
prevent
vaccin
effici
way
prevent
season
pandem
outbreak
influenza
current
licens
influenza
vaccin
mainli
manufactur
fertil
chicken
egg
product
system
method
vaccin
manufactur
capac
restrict
avail
egg
may
insuffici
meet
urgent
requir
vaccin
pandem
outbreak
influenza
pandem
potenti
viru
inactiv
vaccin
shown
induc
antibodi
protect
ferret
nonhuman
primat
safe
toler
human
trial
addit
efficaci
live
attenu
influenza
viru
vaccin
prove
mice
ferret
nonhuman
primat
model
current
licens
vaccin
induc
antibodi
primarili
viral
ha
display
lower
protect
rate
elderli
may
poorli
immunogen
young
children
therefor
develop
effect
vaccin
use
altern
technolog
highli
need
meet
demand
pandem
influenza
prepared
surg
capac
follow
newli
identifi
pandem
influenza
outbreak
advanc
vaccin
wide
rang
virus
caus
diseas
human
noninfecti
viruslik
particl
vlp
selfassembl
spontan
interact
viral
structur
protein
suggest
promis
vaccin
candid
platform
importantli
vlpbase
human
papillomaviru
hpv
vaccin
produc
yeast
insect
cell
system
approv
human
vaccin
influenza
vlp
express
recombin
baculoviru
rbv
system
capabl
confer
protect
immun
homolog
heterolog
strain
pandem
potenti
pandem
influenza
viru
previous
demonstr
protein
composit
vaccin
often
serv
import
guidelin
character
vaccin
well
mechanist
insight
vaccin
synthes
vlp
commonli
consid
compos
viral
structur
protein
requir
maintain
viru
architectur
convent
view
chang
due
enhanc
proteom
techniqu
avail
annot
genom
sequenc
sever
mammalian
speci
recent
proteom
studi
demonstr
envelop
virus
particular
capabl
incorpor
numer
host
protein
interior
lipid
envelop
viru
particl
howev
detail
proteom
inform
influenza
vlp
well
known
despit
extens
preclin
vaccin
studi
present
studi
report
proteom
analysi
well
protect
immun
influenza
vlp
contain
ha
deriv
human
isol
avian
influenza
viru
vlp
proteom
analysi
vlp
identifi
numer
cellular
vector
deriv
protein
well
influenza
viral
protein
ha
spodoptera
frugiperda
cell
use
product
recombin
baculovirus
rbv
vlp
purchas
american
type
cultur
collect
atcc
maintain
sfm
medium
incub
revers
genet
engin
reassort
influenza
viru
hemagglutinin
deriv
gene
deriv
viru
gener
describ
reassort
viru
propag
allanto
caviti
use
elisa
antigen
challeng
experi
describ
previous
influenza
vlp
contain
ha
protein
produc
use
rbv
express
system
previous
describ
briefli
gener
rbv
express
influenza
ha
protein
full
length
ha
cdna
deriv
influenza
viru
clone
pfastbac
transfer
bacmid
recombin
bv
dna
racnpv
transform
cell
ha
protein
contain
delet
polybas
amino
acid
cleavag
site
rbv
express
influenza
ha
protein
gener
bacmid
transfect
insect
cell
harvest
cultur
supernat
day
post
transfect
gener
influenza
vlp
insect
cell
coinfect
rbv
express
ha
protein
multipl
infect
respect
approxim
hour
infect
cell
rbv
cultur
media
contain
releas
vlp
collect
clarifi
low
speed
centrifug
g
cultur
supernat
concentr
filtrat
quixstand
benchtop
system
ge
healthcar
use
hollow
fiber
cartridg
kda
molecular
weight
cutoff
purif
perform
sucros
layer
gradient
ultracentrifug
g
min
protein
concentr
vlp
quantifi
protein
assay
kit
biorad
irvin
ca
biolog
activ
determin
hemagglutin
assay
previous
describ
briefli
highest
dilut
factor
vlp
sampl
inactiv
viru
prevent
aggreg
precipit
hors
erythrocyt
determin
present
hemagglutin
activ
unit
hau
indic
vaccin
activ
protein
compon
purifi
vlp
separ
sdspage
protein
sampl
separ
sdspage
use
miniprotean
biorad
gel
stain
coomassi
brilliant
blue
separ
protein
vlp
slice
fraction
accord
molecular
weight
slice
gel
fragment
use
ingel
digest
accord
previou
method
reduct
alkyl
cystein
perform
incub
sampl
protein
mm
mm
ammonium
bicarbon
mm
mm
ammonium
bicarbon
wash
buffer
exchang
alkyl
protein
gel
ammonium
bicarbon
protein
digest
trypsin
mgml
promega
hr
tryptic
peptid
recov
use
two
extract
step
use
mm
ammonium
bicarbon
vv
acetonitril
contain
vv
trifluoroacet
acid
tfa
digest
peptid
resolv
sampl
solut
contain
formic
acid
acet
acid
peptid
sampl
concentr
trap
column
lc
pack
peptid
elut
column
direct
onto
id
revers
phase
column
proxeon
denmark
flow
rate
nlmin
peptid
elut
gradient
acetonitril
min
ms
mass
spectrometri
msm
spectra
lcqdeca
xp
esi
ion
trap
mass
spectromet
thermo
finnigan
acquir
datadepend
mode
full
ms
mz
rang
scan
follow
three
msm
scan
abund
precursor
ion
ms
spectrum
dynam
exclus
enabl
protein
identif
complet
genom
sequenc
autographa
californica
nucleopolyhedroviru
ncbi
http
wwwncbinihgov
est
sequenc
insect
cell
spodobas
http
biowebensaminrafrspodobas
use
databas
msm
analysi
sequenc
ha
protein
deriv
viru
ad
databas
msm
spectra
analyz
mascot
softwar
ver
matrix
scienc
wwwmatrixsciencecom
valid
identifi
protein
fdr
fals
discoveri
ratio
fewer
use
mascot
decoy
databas
mass
toler
parent
ion
fragment
ion
da
cabamidomethyl
cystein
oxid
methionin
consid
msm
analysi
variabl
modif
tryptic
peptid
balbc
mice
week
old
femal
harlan
laboratori
indianapoli
hous
anim
facil
emori
univers
use
immun
lethal
challeng
studi
group
mice
intramuscularli
immun
pb
solut
contain
hau
either
purifi
vlp
vaccin
partial
unpurifi
vlp
inactiv
whole
influenza
viru
infect
isofluoraneanesthet
mice
inocul
intranas
reassort
influenza
viru
bodi
weight
chang
monitor
two
week
anim
experi
carri
follow
approv
iacuc
protocol
institut
anim
care
use
committe
emori
univers
blood
sampl
collect
week
singl
dose
immun
influenza
viru
specif
antibodi
respons
determin
elisa
use
inactiv
influenza
viru
coat
antigen
previous
describ
briefli
well
microtit
plate
coat
inactiv
influenza
viru
wash
three
time
pb
contain
tween
pbst
block
bsa
h
serial
dilut
serum
sampl
ad
incub
h
hrpconjug
goat
antimous
igg
antibodi
use
secondari
antibodi
determin
total
igg
isotyp
antibodi
specif
viru
ophenylenediamin
opd
use
substrat
absorb
read
nm
determin
statist
signific
twotail
pair
student
test
use
graphpad
prism
softwar
perform
two
group
anim
compar
p
valu
less
consid
signific
influenza
vlp
contain
ha
protein
vlp
produc
harvest
cultur
supernat
insect
cell
coinfect
two
rbv
express
ha
protein
separ
host
cell
cell
debri
remov
cultur
supernat
centrifug
clarifi
prepar
vlp
show
signific
ha
titer
per
mg
total
vlp
protein
prior
purif
process
unpurifi
vlp
tabl
shown
tabl
growth
media
contain
high
level
noninfluenza
viral
protein
remov
solubl
protein
concentr
vlp
perform
ultrafiltr
use
hollow
fiber
filter
cartridg
molecular
weight
cutoff
valu
da
base
quantif
total
vlp
protein
found
nonvir
protein
volum
cultur
supernat
remov
partial
purif
process
recircul
filtrat
concentr
tabl
ha
activ
elut
solut
hollow
fiber
cartridg
indic
ha
activ
associ
vlp
obtain
highli
purifi
influenza
vlp
concentr
vlp
solut
load
discontinu
sucros
densiti
gradient
visibl
white
band
collect
sucros
layer
ultracentrifug
final
approxim
mg
protein
present
initi
unpurifi
vlp
remov
purif
process
tabl
contrast
ha
activ
preserv
recollect
fluid
unit
ha
activ
per
mg
total
vlp
protein
increas
fold
purif
process
tabl
therefor
rbv
express
ha
protein
insect
cell
like
target
onto
cell
membran
incorpor
vlp
function
activ
form
result
suggest
vlp
easili
purifi
high
qualiti
remov
nonparticul
protein
present
cultur
supernat
season
pandem
influenza
vlp
produc
insect
cell
shown
confer
protect
suggest
influenza
vlp
promis
vaccin
candid
howev
protein
compon
vlp
produc
insect
cell
remain
unknown
identifi
protein
compon
purifi
vlp
msm
analysi
protein
vlp
separ
sdspolyacrylamid
gel
divid
fraction
subject
ingel
proteas
digest
gener
polypeptid
fig
tryptic
peptid
detect
high
frequenc
three
time
three
analys
detect
two
three
time
analysi
includ
identif
protein
base
msm
analysi
use
lcq
deca
xp
protein
origin
host
cell
found
associ
vlp
tabl
est
databas
cell
contain
sequenc
est
databas
cell
use
protein
identif
annot
sequenc
homolog
analysi
est
sequenc
perform
use
uniprot
insert
databas
varieti
protein
import
cell
biolog
identifi
repres
shown
fig
host
protein
includ
heat
shock
protein
known
involv
protein
fold
cytoskeleton
protein
alphabeta
tubulin
cytoplasm
actin
also
vlp
found
associ
host
protein
involv
vesicular
traffick
adpribosyl
factor
vesicleassoci
membran
protein
vacuolar
protein
sort
myosin
ii
essenti
light
chain
ribosom
protein
put
ubiquitinribosom
protein
fusion
protein
cell
signal
relat
protein
heterotrimer
guanin
nucleotid
bind
protein
gamma
subunitlik
protein
tabl
addit
mani
protein
enzym
activ
found
rang
addit
protein
includ
relat
reductionoxid
control
metabol
signal
tabl
therefor
result
suggest
mani
host
protein
variou
biolog
function
associ
andor
incorpor
vlp
format
host
cell
inform
genom
databas
contain
known
gene
autographa
californica
nucleopolyhedroviru
made
possibl
identifi
baculovirusderiv
protein
vlp
tabl
expect
mani
vectorderiv
protein
also
found
vlp
proteom
analysi
show
presenc
structur
protein
known
involv
viru
vlp
format
tabl
fig
structur
protein
includ
occlus
deriv
polyhedron
associ
protein
capsid
capsid
associ
protein
envelop
protein
tabl
also
protein
regulatori
andor
enzym
activ
function
found
howev
essenti
phosphoprotein
major
core
protein
small
argininerich
polypeptid
found
known
import
format
nucleoprotein
complex
baculovirion
nonetheless
result
indic
baculovirusderiv
protein
prepar
purifi
vlp
proteom
analysi
result
show
protein
locat
fraction
number
respect
expect
locat
sequenc
coverag
protein
respect
indic
high
accuraci
howev
analysi
result
show
thick
protein
band
fraction
number
contain
baculoviru
envelop
glycoprotein
well
influenza
ha
protein
protein
found
major
protein
fraction
number
although
fraction
also
includ
sever
protein
glutathion
stransferas
sigma
apoptosi
inhibitor
protein
fig
investig
effect
noninfluenza
compon
induc
protect
immun
balbc
mice
immun
intramuscularli
purifi
vlp
partial
purifi
unpurifi
differ
level
puriti
vlp
prepar
use
immun
shown
tabl
also
control
group
mice
immun
inactiv
whole
viru
produc
fertil
egg
substrat
includ
compar
control
fig
dose
vlp
inactiv
viru
vaccin
normal
base
amount
ha
equival
hau
pb
mous
sera
collect
week
post
singl
immun
level
viru
specif
antibodi
determin
elisa
group
vlpvaccin
mice
induc
robust
antibodi
respons
specif
influenza
viru
nonetheless
observ
differ
among
group
immun
vlp
contain
differ
level
noninfluenza
compon
decreas
igg
antibodi
respons
group
mice
immun
unpurifi
vlp
partial
purifi
vlp
p
compar
group
purifi
vlp
show
highest
level
antibodi
specif
viru
fig
importantli
immun
vlp
induc
virusspecif
antibodi
similar
higher
level
compar
inactiv
whole
viru
interestingli
note
partial
purifi
vlp
also
elicit
level
antibodi
respons
statist
differ
compar
purifi
inactiv
viru
vaccin
cytokin
secret
subset
antigenspecif
helper
cell
regul
product
differ
igg
isotyp
thu
distribut
igg
antibodi
isotyp
elicit
vaccin
indic
type
cell
immun
respons
immun
vlp
induc
isotyp
dominantli
regardless
differ
level
noninfluenza
compon
fig
contrast
influenza
vlp
produc
mammalian
cell
previous
demonstr
elicit
isotyp
antibodi
predominantli
interestingli
similar
pattern
domin
antibodi
respons
elicit
whole
inactiv
viru
vaccin
prepar
madindarbi
canin
kidney
mdck
cell
previou
studi
propag
egg
substrat
studi
therefor
result
suggest
differ
pattern
immun
respons
observ
may
reflect
differ
vector
andor
cell
type
produc
vlp
determin
hi
antibodi
titer
differ
group
found
hi
titer
low
rang
consid
low
hemagglutin
inhibit
hi
titer
induc
vaccin
mice
thu
import
determin
protect
efficaci
vaccin
mice
vlp
contain
differ
level
noninfluenza
compon
week
singl
dose
immun
mice
challeng
lethal
dose
homolog
viru
infect
given
dose
mice
show
sever
loss
bodi
weight
die
contrast
group
mice
receiv
singl
dose
highli
purifi
partial
purifi
vlp
show
loss
bodi
weight
protect
observ
inactiv
whole
viru
group
fig
meanwhil
group
mice
immun
unpurifi
vlp
display
moder
loss
bodi
weight
transient
fig
recov
normal
weight
although
mice
group
surviv
fig
result
suggest
highli
partial
purifi
vlp
provid
compar
protect
immun
inactiv
whole
viral
vaccin
even
singl
dose
unpurifi
vlp
provid
surviv
protect
mous
model
influenza
vlp
vaccin
produc
rbv
express
system
insect
cell
known
provid
protect
immun
influenza
viru
thu
suggest
promis
vaccin
candid
despit
fact
vlp
clinic
relev
vaccin
signific
gap
understand
detail
inform
vlp
format
composit
present
studi
describ
proteom
analysi
well
immunogen
influenza
vlp
previou
studi
hostencod
protein
detect
influenza
viru
particl
propag
mdck
cell
coronaviru
infecti
bronchiti
viru
particl
shown
associ
host
protein
embryon
chicken
egg
proteom
analysi
vlp
identifi
cellular
protein
assign
function
descript
import
note
insect
cell
protein
identifi
studi
report
present
type
envelop
viru
particl
tabl
despit
use
differ
cell
type
divers
virus
differ
analyt
method
virus
vlp
seem
share
fundament
featur
suggest
host
protein
may
involv
process
viru
vlp
product
common
featur
virus
vlp
produc
bud
result
acquisit
envelop
deriv
host
cell
possibl
explan
host
protein
found
commonli
incorpor
may
play
role
particular
stage
format
envelop
virus
vlp
also
like
vlp
produc
releas
cultur
supernat
follow
common
similar
cellular
pathway
envelop
virus
insect
cell
deriv
protein
could
classifi
function
group
includ
cytoskelet
protein
heat
shock
protein
ribosom
protein
metabol
enzym
among
cytoskelet
protein
tubulin
actin
involv
transport
viral
compon
cell
also
known
requir
viral
gene
express
particularli
rna
virus
encod
protein
report
virus
includ
human
immunodefici
viral
protein
vlp
produc
cytosol
host
cell
incorpor
viral
protein
vlp
may
depend
cellular
transport
machineri
consist
cytoskelet
vesicular
traffick
protein
shown
tabl
exampl
cytoskelet
protein
found
virion
tubulin
sever
envelop
virus
includ
influenza
viru
vlp
therefor
regardless
cell
type
cytoskelet
protein
may
play
import
role
format
vlp
similar
case
envelop
viru
product
heatshock
protein
hsp
known
multifunct
protein
role
fold
unfold
protein
vesicular
transport
process
prevent
protein
aggreg
cytosol
hsp
shown
interact
variou
viral
protein
viru
product
may
involv
assembl
adenoviru
enteroviru
vaccinia
viru
hsp
found
influenza
vlp
produc
insect
cell
consist
result
influenza
vlp
produc
mammalian
cell
interestingli
vlp
also
found
contain
fatti
acidbind
protein
report
present
virion
fabp
famili
carrier
protein
longchain
fatti
acid
accomplish
lipid
organ
influenza
ha
protein
fatti
acid
bind
moieti
although
potenti
role
vlp
format
clear
also
identifi
less
well
known
host
protein
includ
ribosom
protein
signal
transduct
relat
protein
gprotein
glyceraldehyd
dehydrogenas
describ
virion
produc
monocytederiv
macrophag
addit
vlp
found
contain
protein
previous
undetect
virion
relat
ubiquitin
oxidationreduct
translat
regul
calcium
modul
calmodulin
clear
role
protein
might
product
vlp
insect
cell
vlp
describ
studi
deriv
rbv
express
influenza
ha
protein
despit
clinic
relev
vaccin
candid
base
vlp
vectorderiv
compon
vlp
describ
previous
addit
ha
proteom
analysi
identifi
baculovirusderiv
protein
tabl
includ
capsid
envelop
structur
protein
regulatori
protein
baculoviru
protein
requir
influenza
vlp
format
sinc
influenza
vlp
produc
mammalian
cell
like
process
bud
lend
entrap
protein
present
bud
site
vlp
assembl
note
protein
essenti
baculoviru
format
includ
phosphoprotein
major
core
protein
argininerich
polypeptid
found
vlp
prepar
indic
baculoviru
copurif
vlp
minim
interest
note
host
viral
protein
appear
similar
size
fraction
differ
fraction
exampl
protein
involv
vesicular
traffickingactin
cytoskeleton
translat
enzym
protein
fold
observ
variou
isoform
fraction
tabl
also
structur
capsid
viral
protein
detect
differ
molecular
fraction
tabl
specul
multipl
isoform
protein
similar
differ
size
involv
host
cellular
function
viral
protein
product
assembl
traffick
bud
releas
phenomenon
similarli
report
previou
studi
viral
particl
infect
host
cell
proteom
import
determin
effect
noninfluenza
compon
protect
vaccin
efficaci
sinc
mani
vaccin
contain
heterogen
compon
addit
vaccin
antigen
target
unpurifi
vlp
contain
fold
nonvlp
protein
compar
purifi
vlp
use
proteom
analysi
noninfluenza
protein
unpurifi
partial
purifi
protein
origin
cultur
media
tabl
presenc
excess
media
protein
vlp
vaccin
seem
moder
interfer
immun
respons
slightli
lower
protect
efficaci
shown
weight
loss
possibl
excess
noninfluenza
protein
may
decreas
effect
interact
ha
antigen
immun
cell
support
possibl
partial
purifi
vlp
fold
noninfluenza
protein
compar
purifi
vlp
induc
similar
protect
efficaci
despit
lower
level
antibodi
respons
also
observ
vaccin
fold
higher
dose
unpurifi
vlp
induc
complet
protect
without
loss
bodi
weight
data
shown
first
time
proteom
analysi
rbvderiv
vlp
identifi
signific
number
protein
deriv
insect
cell
baculoviru
despit
presenc
host
vector
deriv
protein
vlp
vaccin
confer
higher
noninferior
protect
efficaci
compar
whole
inactiv
viral
vaccin
split
vaccin
common
format
season
vaccin
us
known
less
immunogen
compar
whole
viral
vaccin
preliminari
studi
suggest
rbvderiv
influenza
vlp
vaccin
superior
licens
split
vaccin
induc
protect
immun
data
shown
addit
rbvderiv
vlp
demonstr
activ
innat
immun
cell
dendrit
cell
importantli
studi
show
rbvderiv
vlp
elicit
domin
isotyp
antibodi
indic
helper
type
immun
respons
contrast
mammalian
produc
vlp
antibodi
known
interact
effici
complement
fc
receptor
virtu
fc
domain
properti
contribut
effect
viral
clearanc
probabl
due
singl
immun
low
dose
vlp
vaccin
hau
vaccin
equival
approxim
ug
total
protein
purifi
vlp
low
hi
titer
observ
vaccin
mice
consist
previou
studi
also
previou
studi
differ
dose
vlp
fold
differ
dosag
result
signific
differ
lung
viral
titer
although
vaccin
group
show
lower
lung
viral
titer
compar
mock
control
also
demonstr
protect
viru
observ
absenc
serum
hi
activ
vaccin
mice
hi
antibodi
level
low
singl
dose
live
attenu
viru
vaccin
importantli
worth
note
singl
dose
rbvderiv
vlp
confer
complet
protect
observ
present
studi
wherea
two
dose
previous
use
mammalian
cellproduc
influenza
vlp
therefor
summari
proteom
inform
influenza
vlp
help
elucid
mechan
vlp
form
releas
well
new
insight
vlp
induc
protect
immun
onedimension
electrophoresisliquid
chromatographytandem
mass
spectrometri
vlp
fold
increas
protein
puriti
express
revers
ratio
total
protein
amount
base
start
unpurifi
vlp
purif
step
fold
increas
unit
ha
activ
estim
unit
ha
activ
step
divid
unit
ha
activ
start
unpurifi
vlp
unpurifi
vlp
mean
cultur
supernat
rbv
infect
insect
cell
low
speed
centrifug
remov
cell
debri
partial
purifi
vlp
obtain
ultrafiltr
start
unpurifi
vlp
sampl
purifi
vlp
obtain
sucros
gradient
ultracentrifug
partial
purifi
vlp
applic
molecular
weight
estim
est
sequenc
number
gel
slice
fraction
shown
fig
